Beauty Health

Rising Self-Care And Telehealth Trends Will Power Global Expansion

AnalystHighTarget

Not Invested

Consensus Narrative from 4 Analysts

Published

10 Aug 25

Updated

21 Aug 25

AnalystHighTarget's Fair Value

US$2.00

10.5% overvalued

21 Aug

US$2.21

27.7%

1.4%

Author's Valuation

US$2.0

10.5% overvalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$2.0

10.5% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

3.19%

Personal Products revenue growth rate

0.18%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

10.77%

Calculation

US$18.99m

Earnings '28

19.38x

PE Ratio '28

US$368.04m

Market Cap '28

US$368.04m

Market Cap '28

135.29m

No. shares '28

US$2.72

Share Price '28

US$2.72 Share Price '28

Discounted to 2025 @ 10.88% p.a.

US$2.00

Fair Value '25